Literature DB >> 11911342

Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C.

Abdurrahman Sagir, Matthias Wettstein, Tobias Heintges, Dieter Häussinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11911342     DOI： 10.1023/a:1017964002402

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

1.  Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?

Authors:  M Peck-Radosavljevic; J Zacherl; Y G Meng; J Pidlich; E Lipinski; F Längle; R Steininger; F Mühlbacher; A Gangl
Journal:  J Hepatol       Date:  1997-07       Impact factor: 25.083

2.  Thrombocytopenia during interferon alfa therapy.

Authors:  J H Hoofnagle
Journal:  JAMA       Date:  1991-08-14       Impact factor: 56.272

Review 3.  Side effects of alpha interferon.

Authors:  P F Renault; J H Hoofnagle
Journal:  Semin Liver Dis       Date:  1989-11       Impact factor: 6.115

4.  Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry.

Authors:  G P Visentin; K Wolfmeyer; P J Newman; R H Aster
Journal:  Transfusion       Date:  1990-10       Impact factor: 3.157

5.  Immune thrombocytopenia and alpha-interferon therapy.

Authors:  S P Dourakis; M Deutsch; S J Hadziyannis
Journal:  J Hepatol       Date:  1996-12       Impact factor: 25.083

6.  A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group.

Authors:  P Glue; R Rouzier-Panis; C Raffanel; R Sabo; S K Gupta; M Salfi; S Jacobs; R P Clement
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

7.  Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B.

Authors:  M Sata; Y Yano; Y Yoshiyama; T Ide; R Kumashiro; H Suzuki; K Tanikawa
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

Review 8.  Pegylated interferons: what role will they play in the treatment of chronic hepatitis C?

Authors:  M L Shiffman
Journal:  Curr Gastroenterol Rep       Date:  2001-02

9.  Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy.

Authors:  K C Conlon; W J Urba; J W Smith; R G Steis; D L Longo; J W Clark
Journal:  Cancer       Date:  1990-05-15       Impact factor: 6.860

10.  Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection.

Authors:  R Shrestha; C McKinley; B M Bilir; G T Everson
Journal:  Am J Gastroenterol       Date:  1995-07       Impact factor: 10.864
  10 in total
  6 in total

1.  Interferon-alpha induced severe thrombocytopenia: a case report and review of the literature.

Authors:  Li Li; Da-Kang Han; Jun Lu
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

2.  Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature.

Authors:  Rosario Arena; Paolo Cecinato; Andrea Lisotti; Federica Buonfiglioli; Claudio Calvanese; Giuseppe Grande; Marco Montagnani; Francesco Azzaroli; Giuseppe Mazzella
Journal:  World J Hepatol       Date:  2015-06-28

3.  Haematological effects of interferon-beta-1a (Rebif) therapy in multiple sclerosis.

Authors:  Peter Rieckmann; Paul O'Connor; Gordon S Francis; Graham Wetherill; Enrica Alteri
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Short-term intravenous interferon therapy for chronic hepatitis B.

Authors:  Hiroaki Okushin; Toru Ohnishi; Kazuhiko Morii; Koichi Uesaka; Shiro Yuasa
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

5.  The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report.

Authors:  Rita Lebano; Valerio Rosato; Mario Masarone; Marco Romano; Marcello Persico
Journal:  BMC Res Notes       Date:  2014-01-24

6.  Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report.

Authors:  Weimin Jiang; Hisashi Hidaka; Takahide Nakazawa; Hiroyuki Kitagawa; Wasaburo Koizumi
Journal:  BMC Res Notes       Date:  2014-03-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.